Muhammad S. Rauf

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Journal: Blood advances

Published: February 05, 2026

Salvage Therapy for Relapsed/Refractory Testicular Germ Cell Tumors: King Faisal Hospital and Research Center, Riyadh Experience.

Salvage Therapy for Relapsed/Refractory Testicular Germ Cell Tumors: King Faisal Hospital and Research Center, Riyadh Experience.

Journal: Research and reports in urology

Published: December 24, 2025

Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival.

Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival.

Journal: Cancers

Published: October 24, 2025

Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia.

Docetaxel versus androgen receptor pathway inhibitors as first-line therapy for metastatic castration-resistant prostate cancer after doublet therapy: a multicenter retrospective study from Saudi Arabia.

Journal: BMC urology

Published: July 24, 2025

Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma.

Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma.

Journal: Frontiers in oncology

Published: June 02, 2025

Impact of Risk Factors on Long-Term Survival and Post-Transplant Failure Management in 200 Aggressive Non-Hodgkin Lymphoma Patients Who Underwent High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Impact of Risk Factors on Long-Term Survival and Post-Transplant Failure Management in 200 Aggressive Non-Hodgkin Lymphoma Patients Who Underwent High-Dose Chemotherapy and Autologous Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: May 02, 2025

Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 18, 2025

Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study

Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: October 28, 2024

Outcomes of Autologous stem cell transplantation in patients with primary refractory Diffuse Large B-cell lymphoma who demonstrate chemosensitivity to salvage chemotherapy.

Outcomes of Autologous stem cell transplantation in patients with primary refractory Diffuse Large B-cell lymphoma who demonstrate chemosensitivity to salvage chemotherapy.

Journal: Clinical hematology international

Published: January 26, 2024

Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.

Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant.

Journal: Transplantation and cellular therapy

Published: December 27, 2022

Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience.

Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 02, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026